Literature DB >> 23025350

Identification of pim kinases as novel targets for PJ34 with confounding effects in PARP biology.

Albert A Antolín1, Xavier Jalencas, José Yélamos, Jordi Mestres.   

Abstract

Small molecules are widely used in chemical biology without complete knowledge of their target profile, at risk of deriving conclusions that ignore potential confounding effects from unknown off-target interactions. The prediction and further experimental confirmation of novel affinities for PJ34 on Pim1 (IC(50) = 3.7 μM) and Pim2 (IC(50) = 16 μM) serine/threonine kinases, together with their involvement in many of the processes relevant to PARP biology, questions the appropriateness of using PJ34 as a chemical tool to probe the biological role of PARP1 and PARP2 at the high micromolar concentrations applied in most studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23025350     DOI: 10.1021/cb300317y

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  31 in total

Review 1.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

2.  KIFC1 is a novel potential therapeutic target for breast cancer.

Authors:  Yonghe Li; Wenyan Lu; Dongquan Chen; Rebecca J Boohaker; Ling Zhai; Indira Padmalayam; Krister Wennerberg; Bo Xu; Wei Zhang
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

3.  Synthesis, pharmacological evaluation and molecular docking of pyranopyrazole-linked 1,4-dihydropyridines as potent positive inotropes.

Authors:  Rakesh Kumar; Neha Yadav; Rodolfo Lavilla; Daniel Blasi; Jordi Quintana; José Manuel Brea; María Isabel Loza; Jordi Mestres; Mamta Bhandari; Ritu Arora; Rita Kakkar; Ashok K Prasad
Journal:  Mol Divers       Date:  2017-04-25       Impact factor: 2.943

Review 4.  Shifting from the single to the multitarget paradigm in drug discovery.

Authors:  José L Medina-Franco; Marc A Giulianotti; Gregory S Welmaker; Richard A Houghten
Journal:  Drug Discov Today       Date:  2013-01-20       Impact factor: 7.851

5.  Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors.

Authors:  Albert A Antolín; Jordi Mestres
Journal:  Oncotarget       Date:  2014-05-30

6.  Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus.

Authors:  Daniel Reker; Tiago Rodrigues; Petra Schneider; Gisbert Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

7.  Characterization of V. cholerae T3SS-dependent cytotoxicity in cultured intestinal epithelial cells.

Authors:  Kelly A Miller; Mudit Chaand; Stacy Gregoire; Takeshi Yoshida; Lisa A Beck; Andrei I Ivanov; Michelle Dziejman
Journal:  Cell Microbiol       Date:  2016-07-22       Impact factor: 3.715

Review 8.  Counting on natural products for drug design.

Authors:  Tiago Rodrigues; Daniel Reker; Petra Schneider; Gisbert Schneider
Journal:  Nat Chem       Date:  2016-04-25       Impact factor: 24.427

Review 9.  Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes.

Authors:  Carles Cantó; Anthony A Sauve; Peter Bai
Journal:  Mol Aspects Med       Date:  2013-01-25

10.  PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury.

Authors:  Bogdan A Stoica; David J Loane; Zaorui Zhao; Shruti V Kabadi; Marie Hanscom; Kimberly R Byrnes; Alan I Faden
Journal:  J Neurotrauma       Date:  2014-01-29       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.